JPH07500905A - バイオ活性物質の免疫活性を測定するための方法と組成物 - Google Patents

バイオ活性物質の免疫活性を測定するための方法と組成物

Info

Publication number
JPH07500905A
JPH07500905A JP5507380A JP50738093A JPH07500905A JP H07500905 A JPH07500905 A JP H07500905A JP 5507380 A JP5507380 A JP 5507380A JP 50738093 A JP50738093 A JP 50738093A JP H07500905 A JPH07500905 A JP H07500905A
Authority
JP
Japan
Prior art keywords
pbl
cytokines
ttp
tested
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5507380A
Other languages
English (en)
Japanese (ja)
Inventor
イングロット、アンナ
ブラコルスゼフスカ、ゾフィア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torf Establishment
Original Assignee
Torf Establishment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Establishment filed Critical Torf Establishment
Publication of JPH07500905A publication Critical patent/JPH07500905A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP5507380A 1991-10-26 1992-09-28 バイオ活性物質の免疫活性を測定するための方法と組成物 Pending JPH07500905A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
EP91118269.9 1991-10-26
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (1)

Publication Number Publication Date
JPH07500905A true JPH07500905A (ja) 1995-01-26

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5507380A Pending JPH07500905A (ja) 1991-10-26 1992-09-28 バイオ活性物質の免疫活性を測定するための方法と組成物

Country Status (22)

Country Link
US (1) US5543300A (enEXAMPLES)
EP (2) EP0539610A1 (enEXAMPLES)
JP (1) JPH07500905A (enEXAMPLES)
AT (1) ATE153763T1 (enEXAMPLES)
AU (1) AU678343B2 (enEXAMPLES)
BG (1) BG61705B1 (enEXAMPLES)
CA (1) CA2122131A1 (enEXAMPLES)
CZ (1) CZ100494A3 (enEXAMPLES)
DE (3) DE539610T1 (enEXAMPLES)
DK (1) DK0609255T3 (enEXAMPLES)
ES (1) ES2061424T3 (enEXAMPLES)
FI (1) FI941920L (enEXAMPLES)
GR (3) GR930300100T1 (enEXAMPLES)
HU (1) HU216863B (enEXAMPLES)
LV (1) LV12140B (enEXAMPLES)
NO (1) NO941444L (enEXAMPLES)
PL (1) PL170592B1 (enEXAMPLES)
RO (1) RO114837B1 (enEXAMPLES)
RU (1) RU2125727C1 (enEXAMPLES)
SG (1) SG72665A1 (enEXAMPLES)
SK (1) SK44094A3 (enEXAMPLES)
WO (1) WO1993008470A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016786A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Oxihumic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
AU1360492A (en) * 1991-03-16 1992-10-21 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
DK0609255T3 (da) 1997-12-22
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
DE69220078T2 (de) 1997-12-04
US5543300A (en) 1996-08-06
NO941444D0 (no) 1994-04-21
DE539610T1 (de) 1993-12-16
HK1002610A1 (en) 1998-09-04
WO1993008470A1 (en) 1993-04-29
GR3024457T3 (en) 1997-11-28
ATE153763T1 (de) 1997-06-15
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
SK44094A3 (en) 1995-03-08
GR940300077T1 (en) 1994-11-30
FI941920A7 (fi) 1994-04-25
GR930300100T1 (enEXAMPLES) 1993-10-29
FI941920A0 (fi) 1994-04-25
LV12140B (lv) 1998-12-20
HU9401185D0 (en) 1994-07-28
AU2650992A (en) 1993-05-21
ES2061424T1 (es) 1994-12-16
HU216863B (hu) 1999-09-28
CZ100494A3 (en) 1994-11-16
BG61705B1 (bg) 1998-03-31
SG72665A1 (en) 2000-05-23
CA2122131A1 (en) 1993-04-29
DE69220078D1 (de) 1997-07-03
RU94022481A (ru) 1996-09-27
NO941444L (no) 1994-06-16
ES2061424T3 (es) 1997-10-01
RU2125727C1 (ru) 1999-01-27
EP0539610A1 (en) 1993-05-05
FI941920L (fi) 1994-04-25
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
HUT69990A (en) 1995-09-28
EP0609255B1 (en) 1997-05-28
BG98720A (bg) 1995-07-28

Similar Documents

Publication Publication Date Title
Elmendorf Jr et al. The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man
MacLean et al. Host resistance in sepsis and trauma
Haahr et al. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus
JPH07500905A (ja) バイオ活性物質の免疫活性を測定するための方法と組成物
Argov et al. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome
Saxena et al. Lectin-induced cytotoxic activity in spleen cells from young and old mice. Age-related changes in types of effector cells, lymphokine production and response
Olson et al. Levamisole: a new treatment for recurrent aphthous stomatitis
Jonsson et al. Elevated serum interferon levels in patients with Bell's palsy
Turco et al. Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines
Kirchner et al. Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free interval
Fiorilli et al. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency
Cossart et al. Australia-SH antigen in hepatitis patients in London
KANEGANE et al. Kawasaki disease with a concomitant primary Epstein‐Barr virus infection
Feldman et al. Functional deficiencies in two distinct interferon α-producing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients
Ellenbogen et al. Effect of D-sorbitol on absorption of vitamin B12 by pernicious anemia patients.
Szigeti et al. Interferon suppresses antigen-and mitogen-induced leukocyte migration inhibition
Gollan et al. Red cell aplasia following prolonged D-penicillamine therapy.
Stratton et al. Reactions of anti-human brain serum with human lymphocyte subpopulations
Snyder et al. Further observations on the treatment of typhus fever with para-aminobenzoic acid
Gitlin The hypogammaglobulinemias
US5580769A (en) CD8+ cell antiviral factor
Chapman et al. The two-step leukocyte migration inhibition factor (LIF) assay: Its use in evaluation of cellular immune function in patients with immunodeficiency diseases
Inglot et al. Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system
Heine et al. The Kinetics of Interferon Production by Mouse Lymphocytes and Its Modulating Effect on the Virus Plaque-Forming Cell Assay As a Quantitative Method to Determine Activated Lymphocytes
Flaherty et al. The effect of Lasso® herbicide on human immune function as measured by in vitro assays